Chiva Pharmaceuticals, Inc.

Financings In the fourth quarter of 2011, biopharma start-ups raised a whopping $693 million – 131% more than Q3. This is the most money generated in this sector since we started running this Quarterl

2 Private investment in China is booming, but VCs, be they Chinese nationals or Western investors setting up shop in the Middle Kingdom, are shying away from early-stage biotech. Not Gerald Chan, DSc,

In Vitro Diagnostics Mergers & Acquisitions Opko Health Inc. Claros Diagnostics Inc. Opko Health Inc. (drugs and diagnostics) has acquired privately held point-of-care testing company Claros Dia

A look at financing, M&A, and alliance activity January-March 2011 In this issue, we present another installment of our quarterly review of pharmaceutical/biotechnology dealmaking – for the first quar